A significant correlation between the plasma levels of coenzyme Q10 and vitamin B-6 and a reduced risk of coronary artery disease

Nutrition Research

Volumn 32, Issue 10, 2012, Pages 751-756

  Lee, Bor Jen ^a,b   Yen, Chi Hua ^a,c   Hsu, Hui Chen ^a   Lin, Jui Yuan ^a   Hsia, Simon ^d   Lin, Ping Ting ^a,c  

^a CHUNG SHAN MEDICAL UNIVERSITY   (Taiwan)

^b TAICHUNG VETERANS GENERAL HOSPITAL   (Taiwan)

^c CHUNG SHAN MEDICAL UNIVERSITY HOSPITAL   (Taiwan)

^d HUNGKUANG UNIVERSITY   (Taiwan)

Author keywords

Case control study; Coenzyme Q10; Coronary artery disease; Nutrition; Vitamin B 6

Indexed keywords

CREATININE; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; LOW DENSITY LIPOPROTEIN CHOLESTEROL; NITROGEN; PYRIDOXINE; TRIACYLGLYCEROL; UBIDECARENONE; UREA;

AGED; ARTICLE; BODY MASS; CARDIOVASCULAR RISK; CASE CONTROL STUDY; CHOLESTEROL BLOOD LEVEL; CLINICAL ARTICLE; CONTROLLED STUDY; CORONARY ARTERY DISEASE; CREATININE BLOOD LEVEL; DIASTOLIC BLOOD PRESSURE; DIETARY INTAKE; FEMALE; HEART CATHETERIZATION; HUMAN; MALE; PRIORITY JOURNAL; RISK REDUCTION; SYSTOLIC BLOOD PRESSURE; TRIACYLGLYCEROL BLOOD LEVEL; UREA NITROGEN BLOOD LEVEL; VITAMIN BLOOD LEVEL;

ADULT; AGED; AGED, 80 AND OVER; CASE-CONTROL STUDIES; CHOLESTEROL; CONSTRICTION, PATHOLOGIC; CORONARY ARTERY DISEASE; CORONARY VESSELS; FEMALE; HUMANS; MALE; MIDDLE AGED; NUTRITIONAL STATUS; PYRIDOXAL PHOSPHATE; REFERENCE VALUES; UBIQUINONE; VITAMINS;

EID: 84869094965     PISSN: 02715317     EISSN: 18790739     Source Type: Journal    
DOI: 10.1016/j.nutres.2012.09.003     Document Type: Article

References (31)

1. Ernster L., Dallner G. Biochemical, physiological and medical aspects of ubiquinone function. Biochim Giophys Acta 1995, 1271:195-204.
2. Bhagavan H.N., Chopra R.K. Coenzyme Q10: absorption, tissue uptake, metabolism and pharmacokinetics. Free Radic Res 2006, 40:445-453.
3. Olson R.E., Rudney H. Biosynthesis of ubiquinone. Vital Horm 1983, 40:1-43.
4. Littaru G.P., Ho L., Folkers K. Deficiency of coenzyme Q 10 in human heart disease. I. Int J Vitam Nutr Res 1972, 42:291-305.
5. Littarru G.P., Ho L., Folkers K. Deficiency of coenzyme Q 10 in human heart disease. II. Int J Vitam Nutr Res 1972, 42:413-434.
6. Sarter B. Coenzyme Q10 and cardiovascular disease: a review. J Cardiovasc Nurs 2002, 16:9-20.
7. Tiano L., Belardinelli R., Carnevali P., Principi F., Seddaiu G., Littarru G.P. Effect of coenzyme Q10 administration on endothelial function and extracellular superoxide dismutase in patients with ischaemic heart disease: a double-blind, randomized controlled study. Eur Heart J 2007, 28:2249-2255.
8. Lee B.J., Lin Y.C., Huang Y.C., Ko Y.W., Hsia S., Lin P.T. The relationship between coenzyme Q10 and oxidative stress, antioxidant enzymes activities and coronary artery disease. Sci World J 2012, 2012:792756.
9. Folsom A.R., Nieto F.J., McGovern P.G., Tsai M.Y., Malinow M.R., Eckfeldt J.H., et al. Prospective study of coronary heart disease incidence in relation to fasting total homocysteine, related genetic polymorphisms, and B vitamins: the Atherosclerosis Risk in Communities (ARIC) study. Circulation 1998, 98:204-210.
10. Robinson K., Arheart K., Refsum H., Brattstrom L., Boers G., Ueland P., et al. Low circulating folate and vitamin B6 concentrations: risk factors for stroke, peripheral vascular disease, and coronary artery disease. Eur COMAC Group Circ 1998, 97:437-443.
11. Cui R., Iso H., Date C., Kikuchi S., Tamakoshi A. Dietary folate and vitamin B6 and B12 intake in relation to mortality from cardiovascular diseases: Japan collaborative cohort study. Stroke 2010, 41:1285-1289.
12. Van de Vijver L.P., Weber C., Kardinaal A.F., Grobbee D.E., Princen H.M., van Poppel G. Plasma coenzyme Q10 concentrations are not decreased in male patients with coronary atherosclerosis. Free Radic Res 1999, 30:165-172.
13. Watson P.S., Scalia G.M., Galbraith A., Burstow D.J., Bett N. Lack of effect of coenzyme Q on left ventricular function in patients with congestive heart failure. J Am Coll Cardiol 1999, 33:1549-1552.
14. Martí-Carvajal A.J., Solà I., Lathyris D., Salanti G. Homocysteine lowering interventions for preventing cardiovascular events. Cochrane Database Syst Rev 2009, CD006612.
15. Løland K.H., Bleie O., Blix A.J., Strand E., Ueland P.M., Refsum H., et al. Effect of homocysteine-lowering B vitamin treatment on angiographic progression of coronary artery disease: a Western Norway B Vitamin Intervention Trial (WENBIT) substudy. Am J Cardiol 2010, 105:1577-1584.
16. Chu C.S., Kou H.S., Lee C.J., Lee K.T., Chen S.H., Voon W.C., et al. Effect of atorvastatin withdrawal on circulating coenzyme Q10 concentration in patients with hypercholesterolemia. Biofactors 2006, 28:177-184.
17. Littarru G.P., Mosca F., Fattorini D., Bompadre S. Method to assay coenzyme Q10 in blood plasma or blood serum. United State Patent United State Patent 2007, 7303921:B2.
18. Bates C.J., Pentieva K.D., Matthews N., Macdonald A. A simple, sensitive and reproducible assay for pyridoxal 5'-phosphate and 4-pyridoxic acid in human plasma. Clin Chem Acta 1999, 280:101-111.
19. Tomasetti M., Alleva R., Solenghi M.D., Littarru G.P. Distribution of antioxidants among blood components and lipoproteins: significance of lipids/CoQ10 ratio as a possible marker of increased risk for atherosclerosis. Biofactors 1999, 9:231-240.
20. Molyneux S.L., Florkowski C.M., Lever M., George P.M. Biological variation of coenzyme Q10. Clin Chem 2005, 51:455-457.
21. Molyneux S.L., Young J.M., Florkowski C.M., Lever M., George P.M. Coenzyme Q10: is there a clinical role and a case for measurement?. Clin Biochem Rev 2008, 29:71-82.
22. Stocker R., Keaney J.F. Role of oxidative modification in atherosclerosis. Physiol 2004, 84:1381-1478.
23. Vassalle C., Petrozzi L., Botto N., Andreassi M.G., Zucchelli G.C. Oxidative stress and its association with coronary artery disease and different atherogenic risk factors. J Intern Med 2004, 256:308-315.
24. Pinho R.A., Araújo M.C., Ghisi G.L., Benetti M. Coronary heart disease, physical exercise and oxidative stress. Arq Bras Cardiol 2010, 94:549-555.
25. Lee B.J., Huang Y.C., Chen S.J., Lin P.T. Coenzyme Q10 supplementation reduces oxidative stress and increases antioxidant enzyme activity in patients with coronary artery disease. Nutrition 2012, 28:250-255.
26. 6 status. Biofactors 1999, 9:359-363.
27. Ubbink J.S., van der Merwe A., Delport R., Allen R.H., Stabler S.P., Riezler R., et al. The effect of a subnormal vitamin B6 status on homocysteine metabolism. J Clin Invest 1996, 98:177-184.
28. Lee B.J., Huang Y.C., Chen S.J., Lin P.T. Effects of coenzyme Q10 supplementation on inflammatory markers (high sensitivity C-reactive protein, interleukin-6 and homocysteine) in patients with coronary artery. Nutrition 2012, 28:767-772.
29. Estornell E., Fato R., Castelluccio C., Cavazzoni M., Parenti Castelli G., Lenaz G. Saturation kinetics of coenzyme Q in NADH and succinate oxidation in beef heart mitochondria. FEBS Lett 1992, 311:107-109.
30. Alleva R., Tomasetti M., Battino M., Curatola G., Littarru G.P., Folkers K. The roles of coenzyme Q10 and vitamin E on the peroxidation of human low density lipoprotein subfractions. Proc Natl Acad Sci U S A 1995, 26:9388-9391.
31. Singh U., Devaraj S., Jialal I. Coenzyme Q10 supplementation and heart failure. Nutr Rev 2007, 1:286-293.